Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bottom line is that you (and any warrant holder) is going to have to make a decision sooner rather than later. When this thing goes it is going to happen quick. When you piece t/g Adrian Petrie's statements (his video presentation at harvard, his comments on CES), Titan info and milestones, the JJDC, etc it makes the puzzle more clear. IMO, 3-5 months before something big happens but when i say big, I am not thinking a press release about a new video, I think Big like a buyout and if warrants aren't excercised, you are out of luck.
Anyone waiting for mgmt to provide clarity on our investment will wait a long time, it's not going to happen. THis investment is a read b/t the lines and sift thru the monotony to find the real value and info. I see absolutely NO indication that Titan mgmt is ever going to go this alone and bring Titan to market and wishful thinking isn't good enough to convince me either.
Watch what happens to the robotic surgery players after the Google/JnJ parternship is approved, once the volume picks up in TITXF (300K shares traded, 500k, 600k, et), that means word is out.
Over the past 8 months, anytime I googled Robotic surgery news it would come up that "so and so hospital is now doing Robotic surgery" or "so and so hospital just but a new DaVinci". Now when I google Robotic Surgery the results are about the potential of Google/JnJ in Robotics and this robotic surgical market is going to boom. What this tells me is that there will be a whole lot more people who are going to look into investing in the next robotic company(ies) - this could be setting up for a WILD ride. I can't believe that Medtronic is just going to sit on the sidelines for this one - all we need is one big boy to overpay for us and overpay for us earlier rather than later.
Also, ISRG might want to get in the mix and potentially scoop up Titan to keep it away from competitors and grab their IP. If they were to acquire Titan it could push JnJ/Google's entrance into the market out another 3-4 years.
Great article about the Google/JnJ collaboration - this will certainly continue to put more eyes (and money) on potential robotic surgery companies. Interesting point in the article mentions the R&D time (time to market) of 1-2 years - no way even JnJ/Google could start from scratch and get a robotic surgical platform to market in 1-2 years however 1-2 years matches up perfectly with Titan's timelines - maybe the pieces of the puzzle is starting to fill in.
http://www.wired.com/2015/03/google-robot-surgery/
Note on Dutson, in the SAGES guide, each presenter has to list the companies that pay them (i.e. honorarium, consulting fees, ownership, IP, etc), under Dutson he only has one company and that is Titan - here's where it is interesting his payout is categorized as "Ownership Interest".
Thank you that is exactly my point - you don't understand medical device. I also see your rationale for investing in TRXC, its your money and you can do whatever you want with it.
As for Titan and Sport, I see a company that made the mistake with Amadeus and had the foresight and courage to change direction and develop the next generation robotic surgical platform. No medical device was right the first time it was attempted to be develop, all medical devices go thru reiterations. No great technology was ever right the first time and every great company has failed at times in product development. I would much rather have my money in the next great product and the next great company rather than a company that thinks a couple thousand products is great.
I wish you luck but I am taking your advice and putting you on Ignore so we stop wasting each others time.
The problem is that you don't even know what your saying and that is why you help reinforce that TITXF is a better investment than TRXC. Everytime you make a point, it is easily dismissed within minutes, i.e. you talk about no company would every buy a company making a medical device without FDA approval and within 20 minutes it was proven you didn't have a clue. You talk about TRXC being a rocket ship stock and then they R/S and anyone who invested before that lost their shirts. And on and on and on....
What I am saying is that you don't have a clue on the medical device field and how it operates, what is considered of value to the end user and how companies value potential products. Let me help you, in the medical device realm, innovation and improved clinical outcomes pretty much trump anything. That is why TITXF didn't just copy ISRG b/c they would have died on the vine, instead they work with a reputable company like XIMEDICA to develop an innovative, clinically superior and potentially more cost effective robotic surgery platform.
But you are saying you are a 22-23 year old who has 1-2 years of work experience and none of it in the medical field.
Interesting post from LTG last year right before the bottom fell out of TRXC and the stock plummeted. Sheds a lot of light on his desire to do anything to get people to invest in TRXC, looks like he needs to make all the money he put into TRXC back somehow.
This post is from April 3, 2014
"TRXC SurgiBot will cost $500,000! $300,000 cheaper than SPORT, so TRXC has the advantage, theyll be uplisted to the NYSE by April 21st, and they will be commercializing their product months before the SPORT System!
Good luck, I cashed out of TITXF for nice gain and put it all in TRXC"
you are aware what happens to stocks if you can't sell the product right?
TRXC will need to get their product out soon b/c even after commercialization it will be 2018/2019 before it can get back to $14pps which was the price of TRXC eight months ago. Someone might have to verify that for me, maybe it was $14/share nine months ago - either way, a lot of lost value over the last 8/9 months with upside about 3 years away.
great chance TITXF will be over $150/share in 2018/2019 - Love that return
LTG, here is an example that the world is round.
http://business-technology.co.uk/2012/11/the-world-is-round/
St. Jude buying a company before FDA approval
http://www.mddionline.com/article/st-jude-acquire-heart-failure-startup-cardiomems-before-mid-2014
capital plus recurring revenue stream
wasn't TRXC at $14/share 8 months ago?
That's not accurate, sure companies take risk to acquire technology ahead of market. That is such an uneducated statement.
Its based on technology, market and percieved value to buyer.
Titan Technology - Innovative and nothing like it in the current market
Robotics Market growth - Over $20B in 4 years
Perceived Value - Does JnJ, Medtronic (insert any big company) want to get into Robotics and own the hospital OR.
And no, TRXC patents aren't worth a Billion dollars b/c its crap b/c if it is so good and so close to market, it should have been purchased by now. When Titan gets as close to market as TRXC is right now, Titan will be purchased.
Just a reminder for all those that want to compare Amadeus with SPORT - Titan had no Patent protection or IP technology that was strong enough with Amadeus plus Intuitives patent were still 6 years from expiring. Now with Sport, they have IP technology and patent protection and as any novice finance person will tell you any in-house IP (esp one as innovative as SPORT) has significant value to a potential buyer but no value on the books.
The SPORT technology and IP alone could easily be valued at $500M without ever coming to commercialization, that alone is $5 per share which would increase our investment value (unless it goes up to $14 and then dilutes, which would screw up any investment)
This is the type of milestone achievement that Aidan Petrie (Ximedica) described in his video about value jumps. In his words, an achievement like this will encourage a big company to pursue a deal sooner rather than later. Based on his video, I would expect the behind the scenes negotiations to only intensify which could lead to a very lucrative buyout for all of us by Q4.
Great news and a little surprising given the silence from titan mgmt, really thought it would come in May. Next on the docket, rise in PPS and uplift sometime within the next 6 months.
I'm willing to bet $14 (or the price of one share of TRXC about 8 months ago) that this news will create a value jump in PPS
All I can say about mgmt's lack of communication is that thank goodness Titan's technology is next generation and innovative from what is currently available. And thank goodness Ximedica is running the show on development and not some in-house patchwork of engineers and designers.
Despite mgmt's apparent lack of awareness on running a public company; the technology, IP and platform that Titan has is highly desired by some company who will pay for it to get into that space. If SPORT were just a knockoff or a step back in MIS then I wouldn't be posting on this board b/c I wouldn't be invested.
Actually no it does not scare me, what would scare me is if I invested in TRXC. Couple of months ago it is $14/share, now it is $2.50 or so. I am very familar with Transenterix considering it is in my backyard, I have had friends who have worked for them as well and a network of connections in the RTP area that i relied on for info. A little over a year ago, I had a chance to either invest in TRXC or TITXF to try and capitalize on the growth of Robotic surgery. I could either invest in TRXC at around $8/share at that time or TITXF at around $1/share at the time. My research led me to invest in TITXF and I am up (not much but up), if I had invested in TRXC I would be way down like a lot of people who invested any money in them prior to April of last year.
I added TITXF to my portfolio b/c I think it is an investment (with Risk) that could ultimately provide a life changing reward. I added TITXF b/c it was a 3-5 year investment (knowledge of how medical technology is introduced to the market place and the growth of robotics market) and the technology is significantly better than da Vinci.
My point on the article is that if TRXC can't capitalize on hospital markets in their backyard, how are they going to compete in a global market.
8 press releases and TRXC has gone south, that is a very negative sign considering a press release should drive the stock north. Wasn't that stock at $14 at one point over the last 6 months or so? Would not be surprised to see another delay with TRXC, really have a lot of holes to fill from a personnel perspective to complete surgibot.
TITXF better get their act t/g and announce completion of Q1 milestone over the next 3 weeks rather than wait until May. IMO, it is already completed (thanks Ximedica) and the only reason to delay announcement is to continue the buyout negotiations.
Interesting article about Alamance Regional Medical Center that recently purchased a da Vinci machine. This account is in Transenterix's backyard and with TRXC being so close to commercialization, you would think that a local company would have relationships in place to make sure those capital dollars would be allocated to TRXC system but that didn't happen. Sounds like the TRXC system would be a step back rather than a step forward.
http://www.thetimesnews.com/news/business/business-news/armc-acquires-robotic-surgery-system-1.450797
A little shout out to Ximedica and SPORT in this article 6 days ago. Interesting that of all the devices Ximedica is working on and has delivered on over the years that the author would mention SPORT.
http://blogs.scientificamerican.com/guest-blog/2015/03/02/how-designers-can-improve-health-care-for-everyone/
The only reason I am still invested in Titan is Ximedica, they are the real deal and will get this done. This Q1 milestone will create what Aidan Petrie describes as a "VALUE JUMP" in the development of a product and an increase in PPS. I hope the mgmt announces it in March and doesn't wait until the next MD&A report in May. One more thought to chew on, of all the changes that were dropped on us in November, the one thing that didn't change was Q1 Milestone.
I've talked to surgeons who live the in the RTP area and they have nothing positive to say about Surgibot
TRXC keeps going to these conferences begging investors to invest, they are so, so, so very close to coming to market yet their stock is down BIG TIME b/c there is no more big time investors jumping on board. THAT IS A FACT! LTG invested before it was diluted and now is losing his shirt so he comes on this board b/c he desperately needs us to invest in TRXC.
LTG take your Beta player and I am sure it will work out for you if you are hoping to only lose 75% of your investment. You are so short sighted, your comments on Apollo Hospitals is ridiculous....ass clown.
IMO I couldn't find much value in the report and didn't just want to highlight on the post that TRXC is losing a boatload of money, they are going to dilute the stock again and are delayed again from coming to commercialization. I didn't want to put that out there on the board so I just put the link to the report to allow others to go in and read it for themselves.
Question for the board regarding Warrants: If Titan announces they have an agreeement in place to sell the company before the warrants are excercised, can warrants be exercised after the announcement?
actually JnJ or Medtronic will have SPORT on the market before mid 2017
“The visualization is so much better with the robot — it’s 10 times the magnification of what I’d see in an open surgery,” Dr. Shears says. “I manipulate the instrumentation while sitting in a comfortable console. I can relax and see the sutures precisely as they are.”
http://www.mdnews.com/news/2015_03/game-changing-robotic-assisted-surgery-at-wellspan-york-hospital.aspx
Hey TimesYours, put baby in the corner. Let him out after Q1 milestone completion.
Actually TRXC is being put down b/c of what people know outside the company, that's the problem with TRXC.
So their COO was overseeing their R&D, another reason that Titan/Ximedica is ahead of the game in the development of a robotic surgical platform. Again, doesn't bode well that the COO they fired was overseeing the R&D of their surgical platform and they are still looking for a new Dir of R&D 4 months later. If the product was so good, wouldn't that position be filled? wouldn't a great R&D person jump at the chance to join a company that is right at the goal line in delivering the next great robotic surgical platform? that alone tells me that TRXC is in trouble. Them telling me they will hire a sales force in 2015 has as much stock as them telling me they will have a product available for commercialization in Q2 2015 - not going to happen.
I don't see that they are hiring for any sales people, However they are hiring a Dir. of R&D, maybe it is to redesign their robot to pass the 510k process. You would think that if the Surgibot was special, the R&D director would stay on but they are hiring for one, not a good sign.
http://transenterix.iapplicants.com/ViewJob-653845.html
This is probably why TRXC will struggle mightily compared to Titan b/c they need to hire someone to manage their R&D whereas Titan has Ximedica. Might be why Paul Laviolette scooped up Ximedica and their alliance with Titan to cover his investment in TRXC
TRXC is also looking to hire someone to fill the vacant Dir of R&D, probably not the best sign that this is open when they were supposedly very close to commercialization.
I believe that TRXC is also looking to hire a Dir of R&D, possibly b/c their previous one left. All of a sudden, supposedly this close to commercialization and have to hire an all new Dir of R&D, that is not a good sign. Plus the news that they will dilute again - is it possible that this stock will be close to $2 within a month if not below $2? How far down will dilution take the PPS - sub $1? If any of the technical people can share their thoughts, it would be helpful.
Maybe the TRXC's institutional investors will move over to Titan.
AnesthesiaTITXF... are you sure that the intuitive rep who told you this was not consciously sedated?